- No hay datos
Español
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, the stock price of Materialise, a well-known company in the 3D printing industry, plummeted by 35% overnight. This news was like a heavy bomb, instantly causing a storm in the industry! What exactly happened to Materialise, which was originally developing steadily? Why has there been such a significant drop in stock prices? Today, let's delve into the reasons behind this.The truth behind...
Lithography is one of the core processes in semiconductor manufacturing, and extreme ultraviolet lithography technology, as a new generation lithography technology, is also in a rapid development stage. The basic principle is to use photoresist (also known as photoresist) to form corrosion resistance due to photochemical reactions after being photosensitive, and to engrave the patterns on the mask...
Recently, Phil Energy, a South Korean secondary battery equipment manufacturer, successfully won an order from a European battery manufacturer to manufacture the next generation 46 series cylindrical battery manufacturing equipment. At present, both parties have signed a supply agreement for this cooperation, but have not disclosed the customer name and order size to the public. It is understood...
Laudado&Associates LLC (L&A), an agricultural technology development company headquartered in California, announced the Autonomous Agricultural Solutions Conference held at FIRA Robotics&last week in Salinas, California.This patent pending technology is a completely new design, designed by L&A, aimed at maximizing the commercial feasibility of laser weeding and thinning. It utilize...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...